Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
7.53
+0.22 (3.01%)
At close: Aug 13, 2025, 4:00 PM
7.35
-0.18 (-2.39%)
Pre-market: Aug 14, 2025, 8:40 AM EDT
Bioventus Market Cap
Bioventus has a market cap or net worth of $503.70 million as of August 14, 2025. Its market cap has increased by 7.37% in one year.
Market Cap
503.70M
Enterprise Value
831.45M
1-Year Change
7.37%
Ranking
Category
Stock Price
$7.53
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $503.70M, a decrease of -29.40%. That is a compound annual growth rate of -7.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 503.70M | -26.61% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |